We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mutated Luciferase Generates Bright Light for Optogenetics Technique

By LabMedica International staff writers
Posted on 08 Nov 2016
Print article
Image: Individual neuron glowing with bioluminescent light produced by a new genetically engineered sensor (Photo courtesy of the Johnson Lab, Vanderbilt University).
Image: Individual neuron glowing with bioluminescent light produced by a new genetically engineered sensor (Photo courtesy of the Johnson Lab, Vanderbilt University).
A recent paper described a novel bioluminescent optogenetic technique that used a potent, mutated form of the enzyme luciferase to follow surges of calcium ions in cultured brain cells.

Optogenetics refers to a technique that uses light (usually fluorescence) to control cells in living tissue, typically neurons, which have been genetically modified to express light-sensitive ion channels. This method utilizes a combination of techniques from optics and genetics to control and monitor the activities of individual neurons in living tissue – even within freely-moving animals – and to precisely measure the effects of those manipulations in real-time. Most current optical methods for monitoring Ca++ levels are based on fluorescence excitation that can cause unwanted stimulation of the optogenetic probe and other undesirable effects such as tissue autofluorescence. Luminescence is an alternate optical technology that avoids the problems associated with fluorescence.

Investigators at Vanderbilt University (Nashville, TN, USA) capitalized on a newly developed luciferase (NanoLuc) that is 100-150 times brighter than previous luciferases and which greatly expands the usefulness of luminescence technology. Their Ca++ sensor was genetically encodable to allow targeting to specific cell types and/or cellular loci, and employed this bright new luciferase to obtain excellent signal strength.

The investigators reported in the October 27, 2016, online addition of the journal Nature Communications that this sensor had a large dynamic range and partnered optimally with optogenetic probes. Ca++ fluxes that were elicited by brief pulses of light to cultured cells expressing melanopsin and to neurons-expressing channel rhodopsin were quantified and imaged with the BRET (bioluminescence resonance energy transfer) Ca++ sensor in darkness, thereby avoiding undesirable consequences of fluorescence irradiation.

"Most of the efforts in optical recording use fluorescence, but this requires a strong external light source which can cause the tissue to heat up and can interfere with some biological processes, particularly those that are light sensitive," said senior author Dr. Carl Johnson, professor of biological sciences at Vanderbilt University. "There is an inherent conflict between fluorescent techniques and optogenetics. The light required to produce the fluorescence interferes with the light required to control the cells. Luminescence, on the other hand, works in the dark!"

"For a long time neuroscientists relied on electrical techniques for recording the activity of neurons. These are very good at monitoring individual neurons but are limited to small numbers of neurons. The new wave is to use optical techniques to record the activity of hundreds of neurons at the same time. We have shown that the approach works," said Dr. Johnson. "Now we have to determine how sensitive it is. We have some indications that it is sensitive enough to detect the firing of individual neurons, but we have to run more tests to determine if it actually has this capability."

Related Links:
Vanderbilt University

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.